We are live on
!
Find out more
HQL
abrdn Life Sciences Investors
HQL
HQL
32 hedge funds and large institutions have $42.3M invested in abrdn Life Sciences Investors in 2013 Q2 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
16.12% more ownership
Funds ownership: 0% → 16.12% (+16%)
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
HQL Hedge Fund Activity: Q2 2013 in Review
32 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2013, worth a combined $42.3M.
Buyers outnumbered sellers: 32 funds opened new HQL positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.
- 32 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $42.3M of abrdn Life Sciences Investors stock for Q2 2013.
- 32 funds opened new abrdn Life Sciences Investors positions in Q2 2013 and 0 closed out, a net change of +32 holders.
Based on aggregated 13F filings for Q2 2013.